Form 424B5 Intra-Cellular Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Form 424B5 Intra-Cellular Therapies

Intra-Cellular Therapies (ITCI) PT Raised to $96 at Mizuho

April 22, 2024 5:34 AM EDT

Mizuho analyst Graig Suvannavejh raised the price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $96.00 (from $82.00) while maintaining a Buy rating.

The analyst comments "On the heels of the first Phase 3 data in major depressive disorder/MDD for ITCI's lead asset lumateperone/Caplyta... More